1921
Volume 99, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Melioidosis has a high case fatality rate and is more common in patients with chronic kidney disease. Some authors recommended trimethoprim/sulfamethoxazole (TMP/SMX) prophylaxis for all hemodialysis (HD) patients during the wet season in melioidosis-endemic regions. Historical data were reviewed to determine if TMP/SMX prophylaxis was warranted in the HD population of Far North Queensland, Australia. Between 1997 and 2017, there were 242 culture-confirmed cases of melioidosis in the region, three (1.2%) occurred in HD patients; all survived without intensive care support. During the study period, there were 843 HD patients in the region with 3,024 cumulative patient years of risk. Even assuming 100% efficacy, it would have been necessary to prescribe TMP/SMX for 1,008 patient years to prevent one case of melioidosis. Given the significant additional cost and potentially life-threatening side effects of TMP/SMX therapy, clinicians should review the local epidemiology of melioidosis before the implementation of universal TMP/SMX prophylaxis in their HD population.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0421
2018-07-16
2020-08-03
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/3/tpmd180421.html?itemId=/content/journals/10.4269/ajtmh.18-0421&mimeType=html&fmt=ahah

References

  1. Cheng AC, Currie BJ, 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383416.
    [Google Scholar]
  2. Limmathurotsakul D et al., 2016. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol 1: pii: 15008.
    [Google Scholar]
  3. Chalmers RM, Majoni SW, Ward L, Perry GJ, Jabbar Z, Currie BJ, 2014. Melioidosis and end-stage renal disease in tropical northern Australia. Kidney Int 86: 867870.
    [Google Scholar]
  4. Majoni SW, Hughes JT, Heron B, Currie BJ, 2018. Trimethoprim+Sulfamethoxazole reduces rates of melioidosis in high-risk hemodialysis patients. Kidney Int Rep 3: 160167.
    [Google Scholar]
  5. Stewart JD, Smith S, Binotto E, McBride WJ, Currie BJ, Hanson J, 2017. The epidemiology and clinical features of melioidosis in Far North Queensland: implications for patient management. PLoS Negl Trop Dis 11: e0005411.
    [Google Scholar]
  6. Currie BJ, Ward L, Cheng AC, 2010. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 4: e900.
    [Google Scholar]
  7. Jick H, 1982. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 4: 426428.
    [Google Scholar]
  8. See S, Mumford JM, 2001. Trimethoprim/sulfamethoxazole-induced toxic epidermal necrolysis. Ann Pharmacother 35: 694697.
    [Google Scholar]
  9. Menger RP, Dossani RH, Thakur JD, Farokhi F, Morrow K, Guthikonda B, 2015. Extra-axial hematoma and trimethoprim-sulfamethoxazole induced aplastic anemia: the role of hematological diseases in subdural and epidural hemorrhage. Case Rep Hematol 2015: 374951.
    [Google Scholar]
  10. Bijl AM, Van der Klauw MM, Van Vliet AC, Stricker BH, 1998. Anaphylactic reactions associated with trimethoprim. Clin Exp Allergy 28: 510512.
    [Google Scholar]
  11. Macmorran E, Harch S, Athan E, Lane S, Tong S, Crawford L, Krishnaswamy S, Hewagama S, 2017. The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia. Epidemiol Infect 145: 28172826.
    [Google Scholar]
  12. Berns JS, 2003. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 16: 3037.
    [Google Scholar]
  13. Snyder GM, Patel PR, Kallen AJ, Strom JA, Tucker JK, D’Agata EM, 2013. Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol 34: 349357.
    [Google Scholar]
  14. Suzuki M, Satoh N, Nakamura M, Horita S, Seki G, Moriya K, 2016. Bacteremia in hemodialysis patients. World J Nephrol 5: 489496.
    [Google Scholar]
  15. ANZDATA Registry, 2015. 37th Report, Chapter 3: Mortality in End Stage Kidney Disease. Adelaide, Australia: Australia and New Zealand Dialysis and Transplant Registry.
  16. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R, 2009. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4: 10891096.
    [Google Scholar]
  17. Young A, Tacon C, Smith S, Reeves B, Wiseman G, Hanson J, 2017. Case report: fatal pediatric melioidosis despite optimal intensive care. Am J Trop Med Hyg 97: 16911694.
    [Google Scholar]
  18. Smith S, Stewart J, Tacon C, Archer N, Hanson J, 2017. Children with melioidosis in Far North Queensland are commonly bacteraemic and have a high case fatality rate. Commun Dis Intell Q Rep 41: E318E321.
    [Google Scholar]
  19. Murthy S, Leligdowicz A, Adhikari NK, 2015. Intensive care unit capacity in low-income countries: a systematic review. PLoS One 10: e0116949.
    [Google Scholar]
  20. Schultz MJ et al., Global Intensive Care Working Group of the European Society of Intensive Care Medicine, 2017. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future. Intensive Care Med 43: 612624.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0421
Loading
/content/journals/10.4269/ajtmh.18-0421
Loading

Data & Media loading...

  • Received : 18 May 2018
  • Accepted : 12 Jun 2018
  • Published online : 16 Jul 2018
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error